Related Experiment Video

Updated: May 25, 2026

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

Nitazoxanide for the empiric treatment of pediatric infectious diarrhea

Jean-François Rossignol1, Nicolas Lopez-Chegne, Luis Martin Julcamoro

  • 1Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Transactions of the Royal Society of Tropical Medicine and Hygiene
|February 4, 2012
PubMed

Insights

Nitazoxanide suspension significantly reduced diarrheal illness duration in children. This effective treatment option benefits patients with known or unknown infectious diarrhea causes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Diarrheal illness is a common pediatric concern.
  • Identifying the specific enteropathogen can be challenging.
  • Effective empiric treatment options are needed for pediatric diarrhea.

Purpose of the Study:

  • To evaluate the efficacy of nitazoxanide suspension in treating presumed infectious diarrhea in children.
  • To compare the time to symptom resolution between nitazoxanide and placebo groups.
  • To assess nitazoxanide's effectiveness across different diarrheal etiologies.

Main Methods:

  • Double-blind, placebo-controlled clinical trial.
  • 100 children (mean age 3.3 years) with diarrheal illness (3-29 days) were enrolled.
  • Patients received nitazoxanide or placebo twice daily for three days.

Main Results:

  • Nitazoxanide significantly reduced median time to symptom resolution (23 hours vs. 103.5 hours for placebo, p<0.001).
  • Shorter illness durations were observed in nitazoxanide-treated patients with Giardia lamblia and those with no identified enteropathogen.
  • Nitazoxanide was well-tolerated by study participants.

Conclusions:

  • Nitazoxanide suspension is effective in reducing the duration of infectious diarrhea in children.
  • The drug shows efficacy across various etiologies, including cases with unidentified pathogens.
  • Nitazoxanide presents a viable option for the empiric treatment of pediatric diarrheal illness.

More Related Videos

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease03:25

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease

Published on: December 27, 2024

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...